P.34 - Efficacy and safety of the recommended pegvaliase dosing regimen in adults with phenylketonuria in the phase 3 PRISM studies

Autor: Lindstrom, K, Sacharow, S, Northrup, H, Whitehall, KB, Rowell, R, Burton, B, Thomas, J
Zdroj: In Molecular Genetics and Metabolism May 2022 136 Supplement 1:S23-S23
Databáze: ScienceDirect